BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valoti E, Noris M, Perna A, Rurali E, Gherardi G, Breno M, Parvanova Ilieva A, Petrov Iliev I, Bossi A, Trevisan R, Dodesini AR, Ferrari S, Stucchi N, Benigni A, Remuzzi G, Ruggenenti P. Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes. Front Genet 2019;10:681. [PMID: 31428128 DOI: 10.3389/fgene.2019.00681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Rodríguez FJ, Rios HA, Aguilar MC, Rosenstiehl SM, Gelvez N, Lopez G, Tamayo ML. Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population. Taiwan J Ophthalmol 2019;9:243-8. [PMID: 31942429 DOI: 10.4103/tjo.tjo_72_19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Smolag KI, Fager Ferrari M, Zetterberg E, Leinoe E, Ek T, Blom AM, Rossing M, Martin M. Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE. Front Immunol 2021;12:777402. [PMID: 34858435 DOI: 10.3389/fimmu.2021.777402] [Reference Citation Analysis]
3 Park NH. The Chromosomes and the Kidney. Physician Assistant Clinics 2022. [DOI: 10.1016/j.cpha.2021.11.007] [Reference Citation Analysis]
4 King BC, Blom AM. Complement in metabolic disease: metaflammation and a two-edged sword. Semin Immunopathol 2021. [PMID: 34159399 DOI: 10.1007/s00281-021-00873-w] [Reference Citation Analysis]
5 Cho HY, Park HS, Ko EJ, Ryu CS, Kim JO, Kim YR, Ahn EH, Lee WS, Kim NK. Association of Complement Factor D and H Polymorphisms with Recurrent Pregnancy Loss. Int J Mol Sci 2019;21:E17. [PMID: 31861421 DOI: 10.3390/ijms21010017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Zhao L, Zhang Y, Liu F, Yang H, Zhong Y, Wang Y, Li S, Su Q, Tang L, Bai L, Ren H, Zou Y, Wang S, Zheng S, Xu H, Li L, Zhang J, Chai Z, Cooper ME, Tong N. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. J Endocrinol Invest 2021. [PMID: 34043214 DOI: 10.1007/s40618-021-01596-3] [Reference Citation Analysis]